Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 10/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.33 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | CDC7 | O00311 | 1/20 | 0.32 |
| ▸ | CDK2 | P24941 | 1/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21758584 | 1.00 | GRM5 (0.39) | GRM5KDM4CPTGER4TNKS2DDB1 | |
| SCHEMBL21758592 | 0.97 | GRM5 (0.40) | GRM5KDM4CPTGER4DDB1CRBN | |
| SCHEMBL21397127 | 0.95 | GRM5 (0.42) | GRM5KDM4CPTGER4CDC7CDK2 | |
| SCHEMBL21758725 | 0.92 | GRM5 (0.37) | GRM5KDM4CPTGER4TNKS2KDM4E | |
| SCHEMBL21758739 | 0.92 | GRM5 (0.37) | GRM5KDM4CPTGER4TNKS2TGFBR1 | |
| SCHEMBL21758737 | 0.91 | GRM5 (0.41) | GRM5KDM4CDDB1CRBNCDC7 | |
| SCHEMBL21758591 | 0.91 | GRM5 (0.36) | GRM5KDM4CPTGER4TNKS2TGFBR1 | |
| SCHEMBL21758382 | 0.90 | ATM (0.38) | GRM5KDM4CPTGER4KDM4EALDH1A1 | |
| SCHEMBL21758378 | 0.90 | GRM5 (0.38) | GRM5ALDH1A1 | |
| SCHEMBL21758379 | 0.90 | GRM5 (0.38) | GRM5KDM4CPTGER4TNKS2CDC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OXER1, OR10J3, OXGR1 | GRM5 3349/4885KDM4C 1800/4885PTGER4 1728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.